Analysts expect Candel Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.78 M | 5.39 M | 6.52 M | 45.15 M | 45.65 M | ||||||||||
| Low Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 M | 5.00 M | 5.51 M | 37.26 M | 37.98 M | ||||||||||
| Consensus Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.64 M | 5.20 M | 6.01 M | 41.20 M | 41.81 M |
Analysts expect Candel Therapeutics, Inc. to report earnings per share of -0.32 for Q3 26, against a range of -0.34 to -0.30. The most recent reported quarter, Q2 26, came in at -0.52, a 108.0% miss against the -0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.33 | -0.40 | 0.13 | -0.09 | -0.21 | -0.54 | -0.14 | -0.52 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | -0.22 | -0.33 | -0.14 | -0.18 | -0.23 | -0.30 | -0.23 | -0.30 | -0.28 | -0.31 | -0.32 | -0.31 | -0.33 | 0.09 | -0.04 | ||||||||||
| Low Estimate | - | -0.26 | -0.37 | -0.16 | -0.22 | -0.27 | -0.32 | -0.27 | -0.34 | -0.34 | -0.35 | -0.38 | -0.33 | -0.39 | 0.07 | -0.04 | ||||||||||
| Consensus Estimate | - | -0.24 | -0.35 | -0.15 | -0.20 | -0.25 | -0.31 | -0.25 | -0.32 | -0.31 | -0.33 | -0.35 | -0.32 | -0.36 | 0.08 | -0.04 |
Pull Wall Street consensus for Candel Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CADL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CADL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CADL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();